Intas Pharmaceuticals Limited Citalopram Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Citalopram Export Records India — #12 Exporter, 400 Shipments, $4.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Citalopram

India Pharmaceutical Trade Intelligence

$254.5M257 Suppliers101 CountriesHS 30049099

ExportsIndia → MOROCCO31.6%India → UNITED STATES28.8%

ImportsCANADA → India$5.3M UNITED STATES → India$24.9K

#1 Supplier: MEDISPRAY LABORATORIES #1 Buyer: CIPLA MAROC

Intas Pharmaceuticals Limited — Citalopram Exporter #12 | $4.1M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Citalopram Exporter Profile

Indian Pharmaceutical Exporter · #12 for Citalopram · $4.1M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #12 Indian exporter of Citalopram with $4.1M in export value and 400 verified shipments. Intas Pharmaceuticals Limited holds a 1.6% market share in Citalopram exports across 11 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Citalopram Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Citalopram export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Citalopram?

Country	Value	Shipments	Share
NETHERLANDS	$823.6K	136	45.1%
SOUTH AFRICA	$302.2K	23	16.6%
HONG KONG	$266.1K	25	14.6%
UNITED KINGDOM	$236.4K	35	13.0%

Who Are the Top Buyers of Citalopram from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
TO THE ORDER	MALTA	$492.0K	110
ACCORD HEALTHCARE C/O UPD LEA GLEN	SOUTH AFRICA	$296.1K	22
BROCACEF NL : HUB	NETHERLANDS	$224.1K	51
BROCACEF NL : DUTCH	NETHERLANDS	$129.1K	21
ACCORD UK	UNITED KINGDOM	$100.1K	12
XXCORXXHEAXXHCAXX LTXX	UNITED KINGDOM	$69.8K	8
TO BANK	HONG KONG	$65.5K	5
BROCACEF NL:EU HUB	NETHERLANDS	$60.1K	6
TO THE ORDER.,	HONG KONG	$58.3K	6
I & C (HONGKONG) LIMITED	HONG KONG	$57.8K	5

Intas Pharmaceuticals Limited supplies Citalopram to 30 buyers globally. The largest buyer is TO THE ORDER (MALTA), followed by ACCORD HEALTHCARE C/O UPD LEA GLEN (SOUTH AFRICA) and BROCACEF NL : HUB (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Citalopram Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS & MEDI ESCITALOPRAM 20MG 7X14T(ACCORD-SWEDEN AS PER INVOICE	$111.3K	12
PHARM DRUG&MED:ESCITALOPRAM 10MG 7X14T(ACCORD-SWEDEN)ESCITALOPRAM ACCORD 10MG EACH FILM COATED TABLET CONTAIN (ASPERINV)	$110.4K	6
PH.DRU.& MED.: ACCORD ESCITALOPRAM TABLETS 20MG (EACH TABLET CONTAINS: ESCITALOPRAM 20MG) [2X14T PER PACK]	$100.0K	2
PH.DRU.& MED.: ACCORD ESCITALOPRAM TABLETS 10MG (EACH TABLET CONTAINS: ESCITALOPRAM 10MG) [2X14T PER PACK]	$100.0K	2
CITALOPRAM TAB 10MG 2X14T(ACCORD-UK)	$69.8K	8
PHARMA DRUGS & MEDI ESCITALOPRAM 10MG 2X	$57.8K	12
PHARMA DRUGS & MEDI ESCITALOPRAM 10MG 7X	$52.4K	9
PHARMACEUTICAL DRUGS AND MEDICINE ESCITALOPRAM 10MG 2X14T(ACCORD-NETHERLAND EACHFILM COATED TABLET CONTAINS ESCITALOPR	$50.0K	1
PHARMA DRUGS & MEDI ESCITALOPRAM 10MG 2X14T(ACCORD-NETHERLA AS PER INVOICETBS	$45.4K	9
PHARM DRUG MED ESCITALOPRAM IQB 10MG 2X14T ACO IQ EACH TABLET CONTAINS 10 MG ESCITALOPRAM AS OXALATE ASPERINV	$39.6K	3

Intas Pharmaceuticals Limited exports 188 distinct Citalopram formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDI ESCITALOPRAM 20MG 7X14T(ACCORD-SWEDEN AS with 12 shipments worth $111.3K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Citalopram Exporters?

Exporters ranked immediately above and below #12 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
10	IPCA LABORATORIES LIMITED	$6.0M	156	9	$38.7K
11	GRAVITI PHARMACEUTICALS PRIVATE LIMITED	$5.4M	258	1	$20.9K
12	INTAS PHARMACEUTICALS LIMITED ★	$4.1M	400	11	$10.3K
1	MEDISPRAY LABORATORIES PRIVATE LIMITED	$3.9M	77	1	$50.0K
13	GALPHA LABORATORIES LIMITED.	$3.8M	92	1	$41.8K

Intas Pharmaceuticals Limited ranks #12 among 257 Indian Citalopram exporters. Average shipment value of $10.3K compared to the market average of $579.1K. The closest competitors by value are IPCA LABORATORIES LIMITED and GRAVITI PHARMACEUTICALS PRIVATE LIMITED.

Which Indian Ports Ship Citalopram Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	779	10.6%
SAHAR AIR	684	9.3%
NHAVA SHEVA SEA (INNSA1)	609	8.3%
HYDERABAD ICD	593	8.0%
HYDERABAD ICD (INSNF6)	411	5.6%
HYDERABAD AIR	336	4.6%
DELHI AIR CARGO ACC (INDEL4)	334	4.5%
DELHI AIR	309	4.2%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Citalopram Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Citalopram shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 405 individual customs records matching Intas Pharmaceuticals Limited exporting Citalopram, covering 188 formulations to 11 countries via 30 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 101+ countries, 736+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Citalopram

Citalopram

Intas Pharmaceuticals Limited — Citalopram Exporter Profile

Intas Pharmaceuticals Limited — Citalopram Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Citalopram?

Who Are the Top Buyers of Citalopram from Intas Pharmaceuticals Limited?

What Is India's Total Citalopram Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Citalopram Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Citalopram Exporters?

What Citalopram Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Citalopram to Key Markets

South Africa — SAHPRA

How Does Intas Pharmaceuticals Limited Compare to Nearest Citalopram Exporters?

Which Indian Ports Ship Citalopram Exports?

What Other CNS & Psychiatric Products Does Intas Pharmaceuticals Limited Export?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Citalopram Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Citalopram Export Data from Intas Pharmaceuticals Limited

Citalopram Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source